CustomSurg secures Seed round investment for AI-guided trauma surgery

CustomSurg has closed its Seed round funding which will support key milestones over the next 2 years, including FDA submission and US market entry, to revolutionize trauma surgery with powered predictive analytics.

CustomSurg, a frontrunner in AI-guided trauma surgery solutions, has successfully closed its Seed round of funding led by CHMBR Partners LLC, with backing from renowned international investors like HTGF (High-Tech Gründerfonds) and kickfund. This significant investment, coming at a crucial pre-FDA-approval stage of the company, signals confidence in CustomSurg's innovative approach.

The funding infusion is earmarked to drive CustomSurg through key milestones, spanning FDA submission, first-in-man study, US market entry, clinical research, and regulatory clearances. With this support, CustomSurg aims to redefine trauma surgery by integrating AI-powered predictive analytics into surgical procedures, promising improved outcomes and streamlined workflows.

CustomSurg participated in Venture Leaders Medtech and won the last stage of Venture Kick in 2021.